Forte Biosciences, Inc.

NasdaqCM FBRX

Forte Biosciences, Inc. Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.00

Forte Biosciences, Inc. Dividends Paid is USD 0.00 for the Trailing 12 Months (TTM) ending September 30, 2024. Dividends paid is cash paid to shareholders as a distribution of profits.

Forte Biosciences, Inc. Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 0.00, a 0.00% change year over year.
Forte Biosciences, Inc. Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 0.00.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

NasdaqCM: FBRX

Forte Biosciences, Inc.

CEO	Dr. Paul A. Wagner Ph.D.
IPO Date	April 13, 2017
Location	United States
Headquarters	3060 Pegasus Park Drive
Employees	11
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Key trends

Past 5 years